Received Mar 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | 1 | Y012075 | — |
| MMRV | MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) | MERCK & CO. INC. | UNK | — | — |
No additional AE; inadvertent administration of PROQUAD during a temperature excursion.; This spontaneous report was received from a Registered Nurse and refers to a patient of unspecified age and gender. The patient's concurrent conditions, medical history, previous drug reactions, drug allergies and concomitant therapies were not reported. On 24-Feb-2025, the patient was vaccinated with an improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (involved lot # Y012075, expiration date: 05-Jan-2026) reconstituted with sterile diluent, and administered as prophylaxis (strength, route, and site of administration were not provided) (Product storage error). The administered dose of the vaccine experienced a temperature excursion of 42.83 Fahrenheit degrees for 720 hours 0 minutes 0 seconds. No previous temperature excursion was reported. There was no adverse event reported. No product quality complaint was involved.